[ad_1]
Thousands of blood plasma products sold by a Chinese state-owned pharmaceutical company have been found to be infected with HIV.
More than 12,000 units of plasma have been recalled after products from the same batch have tested positive for the virus, according to state media, The Beijing News.
The lot of intravenous immunoglobulin was produced by Shanghai Xinxing Pharmaceutical Co. Ltd., the second largest blood product manufacturer in the country.
Immunoglobulins, also called antibodies, are produced by plasma cells to fight pathogens in the body.
Intravenous immunoglobulin treatment is often used to treat immune disorders caused by diseases such as leukemia, acute inflammation and chemotherapy.
The presence of the HIV virus in the product was first detected by the Center for Disease Control and Prevention of Jiangxi Province in southeastern China, according to official media reports.
The Beijing News said the Chinese National Health Commission (NHC) had advised hospitals in the country to stop using the contaminated lot and monitor all the patients to whom the treatment had been administered.
According to reports, 12,226 bottles of the product were distributed to a dozen hospitals in different provinces.
Until now, no one has been found infected with HIV because of the treatment, said a representative of the Jianxi Province's Center for Disease Control, who said that "the risk of getting infected with HIV is high." infection by injection of the product is minimal ".
The source of the contamination is probably due to an HIV blood donation.
The case is the latest medical scandal from China.
In July of last year, the Chinese Food and Drug Administration discovered that the vaccine manufacturer Changseng Biotechnology had violated the standards for production of an anti-rabies vaccine.
Eighteen people were reportedly arrested because they were suspected of producing and selling substandard drugs.
ABC
Source link
